HighVista Strategies »

Intra Cellular Therapies shares owned by HighVista Strategies

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2023-09-30 $497k 9.5k 52.09

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Activision Blizzard
Vmware Cl A Com
Albertsons Cos Common Stock (ACI)
Immunovant (IMVT)
Capri Holdings SHS (CPRI)
Horizon Therapeutics Pub L SHS
stock
Seagen
Axsome Therapeutics (AXSM)
Structure Therapeutics Sponsored Ads (GPCR)
Amedisys (AMED)
Ideaya Biosciences (IDYA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Microsoft Corporation (MSFT)

View all positions for HighVista Strategies

Top funds holding Intra Cellular Therapies

Vanguard Group
Daniel D. Thurber
Bellevue Group
venBio Select Advisor
Jpmorgan Chase & Co
Alliancebernstein
Franklin Resources
Wellington Management Company
Jennifer Ranahan
ClearBridge Advisors
Holocene Advisors
T. Rowe Price Associates
Norges Bank Investment Management
Charles Schwab Investment Management
Lord, Abbett & Co

View all funds holding Intra Cellular Therapies